23
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Effect of Antiviral Therapy on Markers of Fibrogenesis in Patients with Chronic Hepatitis C

, , , , &
Pages 659-665 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Frederick D. Coffman. (2008) Chitinase 3-Like-1 (CHI3L1): A Putative Disease Marker at the Interface of Proteomics and Glycomics. Critical Reviews in Clinical Laboratory Sciences 45:6, pages 531-562.
Read now
Julia S Johansen, Benny Vittrup Jensen, Anne Roslind & Paul A Price. (2007) Is YKL-40 a new therapeutic target in cancer?. Expert Opinion on Therapeutic Targets 11:2, pages 219-234.
Read now

Articles from other publishers (15)

Tuula K. Outinen, Paula Mantula, Pia Jaatinen, Mari Hämäläinen, Eeva Moilanen, Antti Vaheri, Heini Huhtala, Satu Mäkelä & Jukka Mustonen. (2019) Glycoprotein YKL-40 Is Elevated and Predicts Disease Severity in Puumala Hantavirus Infection. Viruses 11:9, pages 767.
Crossref
Salvatore Musumeci. 2017. Biomarkers in Liver Disease. Biomarkers in Liver Disease 513 526 .
Sherif El Saadany, Hanan Soliman, Dina H. Ziada, Manal Hamisa, Mohamed Hefeda, Amel Selim & Hussien Goraba. (2016) Fibroscan versus liver biopsy in the evaluation of response among the Egyptian HCV infected patients to treatment. The Egyptian Journal of Radiology and Nuclear Medicine 47:1, pages 1-7.
Crossref
Salvatore Musumeci. 2016. Biomarkers in Liver Disease. Biomarkers in Liver Disease 1 14 .
Camilla Nøjgaard, Julia S. Johansen, Peter Bjerregaard, Stig E. Bojesen & Ulrik Becker. (2015) Plasma YKL-40 in Inuit and Danes. Alcohol and Alcoholism 50:1, pages 11-17.
Crossref
Nicolai A. Schultz & Julia S. Johansen. (2010) YKL-40—A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients?. Cancers 2:3, pages 1453-1491.
Crossref
Julia S JohansenNicolai A Schultz & Benny V Jensen. (2009) Plasma YKL-40: a potential new cancer biomarker?. Future Oncology 5:7, pages 1065-1082.
Crossref
K. Patel, Y. Benhamou, E. M. Yoshida, K. D. Kaita, S. Zeuzem, M. Torbenson, E. Pulkstenis, G. M. Subramanian & J. G. McHutchison. (2009) An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBRO Spect II) during albinterferon alfa-2b combination therapy for chronic hepatitis C . Journal of Viral Hepatitis 16:3, pages 178-186.
Crossref
Anne Roslind & Julia S. Johansen. 2009. Inflammation and Cancer. Inflammation and Cancer 159 184 .
Vera Regina Rodrigues Camacho, Themis Reverbel da Silveira, Jarbas Rodrigues de Oliveira, Sérgio Gabriel Silva de Barros & Carlos Thadeu Schmidt Cerski. (2007) Relationship between serum concetrations of type III procollagen, hyluronic acid and histopathological findings in the liver of HCV-positive blood donors. Arquivos de Gastroenterologia 44:2, pages 118-122.
Crossref
T. Barry Kelleher & Nezam Afdhal. (2005) Noninvasive Assessment of Liver Fibrosis. Clinics in Liver Disease 9:4, pages 667-683.
Crossref
Massimo Pinzani, Krista Rombouts & Stefano Colagrande. (2005) Fibrosis in chronic liver diseases: diagnosis and management. Journal of Hepatology 42:1, pages S22-S36.
Crossref
Yukiko Saitou. (2005) Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV-associated liver disease. World Journal of Gastroenterology 11:4, pages 476.
Crossref
William M.C. Rosenberg, Michael Voelker, Robert Thiel, Michael Becka, Alastair Burt, Detlef Schuppan, Stefan Hubscher, Tania Roskams, Massimo Pinzani & Michael J.P. Arthur. (2004) Serum markers detect the presence of liver fibrosis: A cohort study. Gastroenterology 127:6, pages 1704-1713.
Crossref
Nezam H. Afdhal & David Nunes. (2004) Evaluation of Liver Fibrosis: A Concise Review. The American Journal of Gastroenterology 99:6, pages 1160-1174.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.